Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone plus doxycycline in neuroborreliosis-induced peripheral facial palsy
2009-018143-25Phase 4Completed
- Sponsor
- Region Västra Götaland
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of prednisolone in neuroborreliosis (LNB) and Lyme facial palsy (LFP), sponsored by Region Västra Götaland. Primary endpoint: Monocytic cell level in CNS at 6 weeks after end of treatment. Started Feb 2010; status: completed.
02
Drugs
prednisolone
03
Conditions
neuroborreliosis (LNB)Lyme facial palsy (LFP)
Beyond the preview
Go deeper on 2009-018143-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018143-25.